Iran Pharmaceuticals & Healthcare Q4 2019
The risk profile of the Iranian pharmaceutical market will continue rise for international drugmakers owing to the re-imposition of sanctions. European companies will be most affected as a result of closer trade ties with the country. Iran's growingself-sufficiency is expected to largely bridge the demand gap despite price hikes and the growing scarcity of innovative medicines.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook